Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction

被引:67
作者
Chandrasekaran, Chinampudur V. [1 ]
Sundarajan, Kannan [1 ]
Edwin, Jothie R. [1 ]
Gururaja, Giligar M. [1 ]
Mundkinajeddu, Deepak [1 ]
Agarwal, Amit [1 ]
机构
[1] Nat Remedies Pvt Ltd, R & D Ctr, Bangalore, Karnataka, India
来源
PHARMACOGNOSY RESEARCH | 2013年 / 5卷 / 02期
关键词
Curcuma longa; immunomodulation; inflammation; pain; polysaccharides; Turmacin((TM));
D O I
10.4103/0974-8490.110527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: While curcuminoids have been reported to possess diverse biological activities, the anti-inflammatory activity of polar extracts (devoid of curcuminoids) of Curcuma longa (C. longa) has seldom been studied. In this study, we have investigated immune-stimulatory and anti-inflammatory activities of an aqueous based extract of C. longa (NR-INF-02) and its fractions in presence and absence of mitogens. Materials and Methods: Effects of NR-INF-02 (Turmacin (TM) , Natural Remedies Pvt. Ltd., Bangalore, India) on proliferation, nitric oxide (NO), monocyte chemotactic protein-1 (MCP-1), interleukins (ILs) and prostaglandin (PGE(2)) levels of mouse splenocytes and mouse macrophage (RAW264.7) cells were determined. Results: NR-INF-02 increased splenocytes number in presence and absence of lipopolysaccharide (LPS) or concanavalin A. Treatment of NR-INF-02 showed a significant increase of NO, IL-2, IL-6, IL-10, IL-12, interferon (IFN) gamma, tumor necrosis factor (TNF) alpha and MCP-1 production in unstimulated mouse splenocytes and mouse macrophages. Interestingly, NR-INF-02 showed potent inhibitory effect towards release of PGE(2) and IL-12 levels in LPS stimulated mouse splenocytes. Further, NR-INF-02 was fractionated into polysaccharide fraction (F1) and mother liquor (F2) to study their immune-modulatory effects. F1 was found to be more potent than F2 toward inhibiting PGE(2) and IL-12 in LPS stimulated splenocytes. Conclusion: Present findings revealed the novel anti-inflammatory property of NR-INF-02 and its polysaccharide fraction by inhibiting the secretion of IL-12 and PGE 2 in vitro.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 38 条
  • [1] Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation
    Aggarwal, S
    Ichikawa, H
    Takada, Y
    Sandur, SK
    Shishodia, S
    Aggarwal, BB
    [J]. MOLECULAR PHARMACOLOGY, 2006, 69 (01) : 195 - 206
  • [2] Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells
    Bhaumik, S
    Jyothi, MD
    Khar, A
    [J]. FEBS LETTERS, 2000, 483 (01) : 78 - 82
  • [3] Optimization of cell-based assays to quantify the anti-inflammatory/ allergic potential of test substances in 96-well format
    Chandrasekaran C.V.
    Edwin Jothie R.
    Kapoor P.
    Gupta A.
    Agarwal A.
    [J]. Inflammopharmacology, 2011, 19 (3) : 169 - 181
  • [4] In vitro efficacy and safety of poly-herbal formulations
    Chandrasekaran, C. V.
    Sundarajan, K.
    David, Kripalini
    Agarwal, Amit
    [J]. TOXICOLOGY IN VITRO, 2010, 24 (03) : 885 - 897
  • [5] Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile
    Churchill, M
    Chadburn, A
    Bilinski, RT
    Bertagnolli, MM
    [J]. JOURNAL OF SURGICAL RESEARCH, 2000, 89 (02) : 169 - 175
  • [6] Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis
    Deshpande, SS
    Ingle, AD
    Maru, GB
    [J]. CANCER LETTERS, 1998, 123 (01) : 35 - 40
  • [7] Gomis DB, 2001, ANAL CHIM ACTA, V436, P173, DOI 10.1016/S0003-2670(01)00889-3
  • [8] GONDA R, 1993, BIOL PHARM BULL, V16, P235, DOI 10.1248/bpb.16.235
  • [9] CHARACTERIZATION OF POLYSACCHARIDES HAVING ACTIVITY ON THE RETICULOENDOTHELIAL SYSTEM FROM THE RHIZOME OF CURCUMA-LONGA
    GONDA, R
    TOMODA, M
    SHIMIZU, N
    KANARI, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (02) : 482 - 486
  • [10] GONDA R, 1992, CHEM PHARM BULL, V40, P990, DOI 10.1248/cpb.40.990